What is NeoGenomics's compensation and benefits?

NeoGenomics (NEO) reported compensation and benefits of $40.58M in Q1 2026.

How has NeoGenomics's compensation and benefits changed year-over-year?

NeoGenomics's compensation and benefits increased by 2.8% year-over-year, from $39.49M to $40.58M.

What is the long-term trend for NeoGenomics's compensation and benefits?

Over 5 years (2020 to 2025), NeoGenomics's compensation and benefits has grown at a 14.0% compound annual growth rate (CAGR), from $24.73M to $47.58M.

NeoGenomics NEO Compensation and benefits

Compensation and benefits at other companies

Natera, Inc.NTRA

——

Tempus AI, Inc.TEM

——

Agilent TechnologiesA

——

CareDxCDNA

——

TEC

Bio-TechneTECH

——

VeracyteVCYT

——

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's compensation and benefits?: NeoGenomics (NEO) reported compensation and benefits of $40.58M in Q1 2026.
How has NeoGenomics's compensation and benefits changed year-over-year?: NeoGenomics's compensation and benefits increased by 2.8% year-over-year, from $39.49M to $40.58M.
What is the long-term trend for NeoGenomics's compensation and benefits?: Over 5 years (2020 to 2025), NeoGenomics's compensation and benefits has grown at a 14.0% compound annual growth rate (CAGR), from $24.73M to $47.58M.